Key points from article :
New antibiotic zosurabalpin worked "extremely well" in test-tubes and mice, and now shows promise against drug-resistant bacteria.
Effective against infections caused by the carbapenem-resistant Acinetobacter baumannii (Crab) bacterium.
CRAB causes severe infections in hospitals with high mortality rate.
Zosurabalpin disrupts Crab's protective membrane construction.
Completed "first-in-man" studies & were "set up now to do full clinical trials in people with the infection", - Laura Piddock, GARDP's scientific director.
Commercialization and global access may take years due to cost, but there is definite hope for new antibiotics.
Study led by researchers from Roche, published in the journal Nature.
